CINECA IRIS Institutional Research Information System

QUAGLINO, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.621
EU - Europa 14.278
AS - Asia 6.792
SA - Sud America 420
AF - Africa 189
OC - Oceania 185
Continente sconosciuto - Info sul continente non disponibili 64
Totale 42.549
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.320
IT - Italia 4.398
CN - Cina 2.823
IE - Irlanda 1.994
SG - Singapore 1.685
DE - Germania 1.300
FR - Francia 1.290
SE - Svezia 1.091
KR - Corea 781
FI - Finlandia 748
UA - Ucraina 563
GB - Regno Unito 559
AT - Austria 436
PL - Polonia 434
IN - India 365
ES - Italia 300
VN - Vietnam 290
JP - Giappone 272
CA - Canada 232
DK - Danimarca 199
BR - Brasile 193
NL - Olanda 165
AU - Australia 164
ID - Indonesia 125
TR - Turchia 124
CH - Svizzera 104
GR - Grecia 94
HK - Hong Kong 89
RO - Romania 89
RU - Federazione Russa 88
BE - Belgio 87
AR - Argentina 75
SN - Senegal 68
PT - Portogallo 63
EU - Europa 61
MX - Messico 52
CO - Colombia 50
NO - Norvegia 49
NG - Nigeria 45
TW - Taiwan 44
CL - Cile 43
SI - Slovenia 39
CZ - Repubblica Ceca 35
HU - Ungheria 34
IR - Iran 34
PE - Perù 29
RS - Serbia 24
IL - Israele 22
NZ - Nuova Zelanda 21
EG - Egitto 20
HR - Croazia 19
TH - Thailandia 18
ZA - Sudafrica 17
PH - Filippine 15
AE - Emirati Arabi Uniti 13
EC - Ecuador 13
SA - Arabia Saudita 12
UY - Uruguay 12
LT - Lituania 11
TN - Tunisia 11
BG - Bulgaria 10
DZ - Algeria 9
MY - Malesia 9
UZ - Uzbekistan 9
CR - Costa Rica 8
PK - Pakistan 8
AL - Albania 7
AM - Armenia 7
BA - Bosnia-Erzegovina 7
MO - Macao, regione amministrativa speciale della Cina 7
BY - Bielorussia 6
CI - Costa d'Avorio 6
LV - Lettonia 6
MK - Macedonia 6
SK - Slovacchia (Repubblica Slovacca) 6
LK - Sri Lanka 5
QA - Qatar 5
EE - Estonia 4
KW - Kuwait 4
LB - Libano 4
VE - Venezuela 4
BD - Bangladesh 3
IQ - Iraq 3
JO - Giordania 3
MA - Marocco 3
MT - Malta 3
NP - Nepal 3
PA - Panama 3
A1 - Anonimo 2
FO - Isole Faroe 2
IM - Isola di Man 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
SC - Seychelles 2
Totale 42.533
Salva come PNG Salva come JPEG
Città #
Chandler 2.730
Dublin 1.981
Beijing 1.483
Singapore 1.347
Ashburn 958
Houston 912
Fairfield 870
Princeton 752
Villeurbanne 720
Medford 691
Torino 656
Columbus 629
Wilmington 621
Ann Arbor 550
Jacksonville 543
Santa Clara 505
Woodbridge 480
Redwood City 433
Vienna 411
Nyköping 386
Warsaw 371
Dearborn 339
Seattle 337
Cambridge 327
Milan 287
Boston 263
Pisa 255
Turin 200
Dong Ket 182
Guangzhou 172
New York 160
Rome 160
Hebei 129
Pune 114
Jakarta 109
Boardman 106
Shanghai 103
Norwalk 100
Washington 95
Nanjing 94
Toronto 88
Chengdu 83
Hangzhou 82
Tokyo 79
Fremont 72
Helsinki 69
Florence 66
Seoul 66
Hefei 61
Bologna 59
Munich 58
San Diego 58
Verona 58
Falls Church 57
Paris 55
Brussels 54
Los Angeles 52
São Paulo 52
Madrid 50
Mountain View 50
San Mateo 49
Sydney 45
Lappeenranta 43
Abuja 42
Jinan 42
London 42
Padova 42
Kunming 39
Barcelona 34
Silver Spring 34
Athens 33
Buenos Aires 33
Leiden 32
Hong Kong 31
Napoli 31
Genova 30
Istanbul 30
Phoenix 30
Saluzzo 30
Santiago 29
Palermo 28
Ankara 27
Central District 27
Ottawa 27
Redmond 27
Rochester 27
Taipei 27
Chicago 26
Zhengzhou 25
Zurich 25
Amsterdam 24
Naples 24
Nürnberg 24
Berlin 23
Council Bluffs 23
Bari 22
Copenhagen 22
Mumbai 22
Pavia 22
Philadelphia 22
Totale 24.045
Salva come PNG Salva come JPEG
Nome #
Prediction of survival in patients with thin melanoma: results from a multi-institution study. 810
Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. 722
Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases 678
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: A European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases 609
Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response. 602
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis 506
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 450
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. 364
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab 330
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 316
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 316
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 306
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 304
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 301
Metastasi cutanee da melanoma: l’esperienza della I Clinica Dermatologica di Torino 281
Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. 279
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid 274
Alopecia areata after COVID-19 vaccination 259
Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy 252
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. 251
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 249
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 241
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 238
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 232
Giornale italiano di Dermatologia e Venereologia 228
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients. 225
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 215
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 214
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 213
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 207
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 207
Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis 205
Dermoscopy and digital dermoscopy analysis of palmo-plantar equivocal pigmented skin lesions in Caucasians. 201
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 196
MiR-146a exerts differential effects on melanoma growth and metastatization 195
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 185
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. 184
High nevus counts confer a favorable prognosis in melanoma patients 183
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 181
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 178
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 177
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 177
Autoantibody Profile of a Cohort of 78 Italian Patients with Mucous Membrane Pemphigoid: Correlation Between Reactivity Profile and Clinical Involvement 176
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma 175
Adult-onset cutaneous mastocytosis in monozygotic twins. 172
Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force 171
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 171
Current status and perspectives in immunotherapy for metastatic melanoma 169
Dermatite Flagellata e Melanonichia striata longitudinale da citostatici 167
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 154
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 153
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives 149
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality 147
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma. 143
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 139
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 136
VENTI ANNI DI ESPERIENZA CON LA FOTOFERESI 131
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 131
Prognostic differences across sexes in melanoma patients: What has changed from the past? 130
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 129
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 126
Precursori del melanoma? 125
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 123
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 120
Gruppo Italiano Polidisciplinare sul Melanoma: proposte per nuove studi 119
L'elettrochemioterapia nel trattamento del sarcoma di Kaposi: l'esperienza di Roma e Torino 119
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis. 118
The importance of a multidisciplinary care: community pharmacies as a hub to support oncologic patients with cutaneous reactions due to treatments 117
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. 114
Fotoferesi: applicazioni terapeutiche “off-label” 113
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 112
T-Helper (Th)22, a Newly Identified Lymphocyte Subset, Increases 1-3 Months before an MS Relapse and It Is Not Sensitive to IFN beta 112
Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: A multivariate analysis of 214 cases 112
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 112
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 112
Dermatite flagellata e iperpigmentazione longitudinale a banda ungueale indotta da trattamento chemioterapico: descrizione di un caso. 111
Melanoma immunotherapy. 110
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease. 109
Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. 109
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 108
Linfociti circolanti T regolatori in pazienti psoriasici trattati con ciclosporina e farmaci biologici 107
Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma 106
Dermatite flagellata e melanonichia striata longitudinale da citostatici. 105
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei 104
Peripheral blood involvement in a mycosis fungoides patient with limited skin lesions: phenotypical features and homing molecule pattern 104
Il melanoma primitivo sconosciuto 102
The risk of melanoma in airline pilots and cabin crew: A meta-analysis 102
Unknown Primary Melanoma: Worldwide Survey on Clinical Management. 100
The Risk of Melanoma in Pilots and Cabin Crew: UV Measurements in Flying Airplanes. 98
Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation 98
'Aleukemic' granulomatous leukemia cutis. 96
EPILUMINESCENZA DIGITALE NEI MELANOMI SOTTILI: CORRELAZIONI CON I PARAMETRI CLINICO-PATOLOGICI 96
Gruppo Italiano Polidisciplinare sul melanoma; studi in corso e nuove proposte 96
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 95
Malattia di Destombes-Rosai-Dorfman ad esclusivo interessamento cutaneo: studio istologico, immunoistochimico ed ultrastrutturale di un caso. 95
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors. 95
VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course. 95
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers. 94
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 93
Endothelial and Smooth muscle cell Derived Neuropin-like molecule and AP-2 family protein expression in primary melanoma predicts Disease Free Survival in melanoma patients 93
Totale 19.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.912
article - articoli 0
book - libri 0
conference - conferenze 31.625
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.889 0 0 0 0 426 732 570 421 493 463 387 397
2020/20213.732 475 235 272 222 320 325 253 180 332 346 282 490
2021/20225.649 319 190 256 313 623 212 281 293 235 334 983 1.610
2022/20238.708 1.098 653 206 675 815 2.045 771 644 878 196 451 276
2023/20244.529 473 644 307 282 287 633 179 226 56 342 333 767
2024/20254.312 198 1.036 457 1.145 1.476 0 0 0 0 0 0 0
Totale 44.347